What is ResMed's deferred finance costs, current?

ResMed (RMD) reported deferred finance costs, current of $72.00K in Q1 2026.

How has ResMed's deferred finance costs, current changed year-over-year?

ResMed's deferred finance costs, current decreased by 23.4% year-over-year, from $94.00K to $72.00K.

What is the long-term trend for ResMed's deferred finance costs, current?

Over 3 years (2022 to 2025), ResMed's deferred finance costs, current has grown at a 6.0% compound annual growth rate (CAGR), from $84.00K to $100.00K.

Discontinued — last reported Q4 '18

Current Assets

Deferred Finance Costs, Current

ResMed Deferred Finance Costs, Current decreased by 23.4% to $72.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 23.4%, from $94.00K to $72.00K. Over 3 years (FY 2022 to FY 2025), Deferred Finance Costs, Current shows an upward trend with a 6.0% CAGR.

Analysis

StatementBalance Sheet Statement

SectionCurrent Assets

First reportedQ4 2018

Last reportedQ4 2018

Metric ID: deferred_finance_costs_current

Historical Data

16 periods

	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$84.00K	$94.00K	$100.00K	$99.00K	$98.00K	$95.00K	$102.00K	$97.00K	$100.00K	$104.00K	$94.00K	$94.00K	$100.00K	$101.00K	$94.00K	$72.00K
QoQ Change	—	+11.9%	+6.4%	-1.0%	-1.0%	-3.1%	+7.4%	-4.9%	+3.1%	+4.0%	-9.6%	+0.0%	+6.4%	+1.0%	-6.9%	-23.4%
YoY Change	—	—	—	—	+16.7%	+1.1%	+2.0%	-2.0%	+2.0%	+9.5%	-7.8%	-3.1%	+0.0%	-2.9%	+0.0%	-23.4%

Range$72.00K – $104.00K

CAGR-4.0%

Avg YoY Growth-0.7%

Median YoY Growth+0.0%

Current Streak2 quarters decline

Frequently Asked Questions

What is ResMed's deferred finance costs, current?: ResMed (RMD) reported deferred finance costs, current of $72.00K in Q1 2026.
How has ResMed's deferred finance costs, current changed year-over-year?: ResMed's deferred finance costs, current decreased by 23.4% year-over-year, from $94.00K to $72.00K.
What is the long-term trend for ResMed's deferred finance costs, current?: Over 3 years (2022 to 2025), ResMed's deferred finance costs, current has grown at a 6.0% compound annual growth rate (CAGR), from $84.00K to $100.00K.